WHO Collaborative Study on Substitution Treatment of Opioid Dependence & HIV/AIDS
Regional Comparisons of the Outcomes of Substitution Treatment Therapy of Opioid Dependence: Results of WHO Study
WHO Workshop on Substitution Therapy for Opioid Dependence
Introduction 1: WHO Study
•This study assessed the treatment outcomes of patients recruited at new and existing opioid maintenance treatment programmes in Asia (China, Indonesia, Thailand), Eastern Europe (Lithuania, Poland, Ukraine), the Middle East (Iran), and Australia.
•Patients were assessed at entry to treatment (once withdrawal ceased) and at 3- and 6- month follow-ups
•All assessments related to one month prior to interview
•The main aims of evaluation were to explore changes in the following domains:
•Prevalence of drug use
•Health Status and well being of individuals in substitution treatment
Blood Borne Virus Risk Behaviour BBV-Traq * I I : Sexual practices
Community /Social Benefits
Criminal Activity
Employment Activity
Programme Performance
Programme Performance
Summary
•Participation in ST was associated with:
–decreases in opioid use
–decreases in risky injection practices
–decreases in criminal activity
–improvements inphysical and psychological health
–increases in employment activity
•The mean daily methadone dose used in Australia and Europe was greater than that used in Asia [despite this retention in treatment was comparable].
Conclusions
•Outcome evaluation data from participating sites are consistent with findings from established ST programmes.
•Despite the diversity of sites involved in this study participation in ST was associated with reductions in the prevalence of illicit drug use, reductions in HIV risk behaviors, and with improvements in general health status.